{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:24:16Z","timestamp":1780395856102,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"InovoBiologic Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00394-020-02328-8","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T13:03:43Z","timestamp":1594213423000},"page":"1237-1251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effect of a functional fibre supplement on glycemic control when added to a year-long medically supervised weight management program in adults with type 2 diabetes"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5088-7947","authenticated-orcid":false,"given":"Raylene A.","family":"Reimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Manjoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hena R.","family":"Ramay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland J.","family":"Gahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"2328_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. Lancet 389:3\u20139","journal-title":"Lancet"},{"key":"2328_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Look AHEAD Research Group, Wing RR, Bolin P et al (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369:145\u2013154","journal-title":"N Engl J Med"},{"key":"2328_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pcad.2015.04.002","volume":"58","author":"GR Dutton","year":"2015","unstructured":"Dutton GR, Lewis CE (2015) The Look AHEAD trial: implications for lifestyle intervention in type 2 diabetes mellitus. Prog Cardiovasc Dis 58:69\u201375","journal-title":"Prog Cardiovasc Dis"},{"key":"2328_CR4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3181\/00379727-180-42199","volume":"180","author":"DJ Jenkins","year":"1985","unstructured":"Jenkins DJ, Jenkins AL (1985) Dietary fiber and the glycemic response. Proc Soc Exp Biol Med 180:422\u2013431","journal-title":"Proc Soc Exp Biol Med"},{"key":"2328_CR5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/nure.12076","volume":"7","author":"FM Silva","year":"2013","unstructured":"Silva FM, Kramer CK, de Almeida JC, Steemburgo T, Luiz Gross J, Azevedo MJ (2013) Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev 7:790\u2013801","journal-title":"Nutr Rev"},{"key":"2328_CR6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/dc18-1126","volume":"42","author":"E Jovanovski","year":"2019","unstructured":"Jovanovski E, Khayyat R, Zurbau A, Komishon A, Mazhar N, Sievenpiper JL, Blanco Mejia S, Ho HVT, Li D, Jenkins AL, Duvnjak L, Vuksan V (2019) Should Viscous fiber supplements be considered in diabetes control? results from a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 42:755\u2013766","journal-title":"Diabetes Care"},{"issue":"9","key":"2328_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1475-2891-9-58","volume":"22","author":"AL Jenkins","year":"2010","unstructured":"Jenkins AL, Kacinik V, Lyon M, Wolever TM (2010) Effect of adding the novel fiber, PGX\u00ae, to commonly consumed foods on glycemic response, glycemic index and GRIP: a simple and effective strategy for reducing post prandial blood glucose levels\u2013a randomized, controlled trial. Nutr J 22(9):58","journal-title":"Nutr J"},{"key":"2328_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S0007114511005447","volume":"108","author":"JC Brand-Miller","year":"2012","unstructured":"Brand-Miller JC, Atkinson FS, Gahler RJ, Kacinik V, Lyon MR, Wood S (2012) Effects of added PGX\u00ae, a novel functional fibre, on the glycaemic index of starchy foods. Br J Nutr 108:245\u2013248","journal-title":"Br J Nutr"},{"key":"2328_CR9","doi-asserted-by":"crossref","first-page":"E379","DOI":"10.1002\/oby.20435","volume":"21","author":"RA Reimer","year":"2013","unstructured":"Reimer RA, Yamaguchi H, Eller LK, Lyon MR, Gahler RJ, Kacinik V, Juneja P, Wood S (2013) Changes in visceral adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity. Obesity 21:E379\u2013E387","journal-title":"Obesity"},{"issue":"47","key":"2328_CR10","first-page":"1","volume":"2","author":"GJ Grover","year":"2011","unstructured":"Grover GJ, Koetzner L, Wicks J, Gahler R, Lyon MR, Reimer RA, Wood S (2011) Effects of the soluble fiber complex PolyGlycopleX on glucose homeostasis and body weight in young zucker diabetic rats. Front Pharmacol 2(47):1","journal-title":"Front Pharmacol"},{"key":"2328_CR11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/JOE-13-0484","volume":"220","author":"RA Reimer","year":"2014","unstructured":"Reimer RA, Grover GJ, Koetzner L, Gahler RJ, Lyon MR, Wood S (2014) Combining sitagliptin\/metformin with a functional fiber delays diabetes progression in Zucker rats. J Endocrinol 220:361\u2013373","journal-title":"J Endocrinol"},{"key":"2328_CR12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-131-3-199908030-00004","volume":"131","author":"L Aviles-Santa","year":"1999","unstructured":"Aviles-Santa L, Sinding J, Raskin P (1999) Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 131:182\u2013188","journal-title":"Ann Intern Med"},{"key":"2328_CR13","first-page":"e32","volume":"58","author":"S Wharton","year":"2012","unstructured":"Wharton S, VanderLelie S, Sharma AM, Sharma S, Kuk JL (2012) Feasibility of an interdisciplinary program for obesity management in Canada. Can Fam Physician 58:e32\u2013e38","journal-title":"Can Fam Physician"},{"issue":"4 Suppl 1","key":"2328_CR14","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jada.2008.01.026","volume":"108","author":"LM Delahanty","year":"2008","unstructured":"Delahanty LM, Nathan DM (2008) Implications of the diabetes prevention program (DPP) and look AHEAD clinical trials for lifestyle interventions. J Am Diet Assoc 108(4 Suppl 1):S66\u2013S72","journal-title":"J Am Diet Assoc"},{"key":"2328_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0197-2456(03)00064-3","volume":"24","author":"Look AHEAD Research Group","year":"2003","unstructured":"Look AHEAD Research Group (2003) Look AHEAD (Action for Health in Diabetes): Design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Con Clin Trials 24:610\u2013628","journal-title":"Con Clin Trials"},{"key":"2328_CR16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/ije\/24.2.381","volume":"24","author":"MA Pols","year":"1995","unstructured":"Pols MA, Peeters PH, Bueno-De-Mesquita HB, Ocke MC, Wentink CA, Kemper HC, Collette HJ (1995) Validity and repeatability of a modified Baecke questionnaire on physical activity. Int J Epidemiol 24:381\u2013388","journal-title":"Int J Epidemiol"},{"key":"2328_CR17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/oby.20632","volume":"22","author":"MR Bomhof","year":"2014","unstructured":"Bomhof MR, Saha DC, Reid DT, Paul HA, Reimer RA (2014) Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity 22:763\u2013771","journal-title":"Obesity"},{"key":"2328_CR18","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1096\/fj.201600151R","volume":"30","author":"MR Bomhof","year":"2016","unstructured":"Bomhof MR, Paul HA, Geuking MB, Eller LK, Reimer RA (2016) Improvement in adiposity with oligofructose is modified by antibiotics in obese rats. FASEB J 30:2720\u20132732","journal-title":"FASEB J"},{"key":"2328_CR19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/nar\/gkt1244","volume":"42","author":"JR Cole","year":"2014","unstructured":"Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, Brown CT, Porras-Alfaro A, Kuske CR, Tiedje JM (2014) Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucl Acids Res 42:633\u2013642","journal-title":"Nucl Acids Res"},{"key":"2328_CR20","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12:R60","journal-title":"Genome Biol"},{"key":"2328_CR21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/01621459.1987.10478551","volume":"82","author":"DC Hoaglin","year":"1987","unstructured":"Hoaglin DC, Iglewicz B (1987) Fine tuning some resistant rules for outlier labeling, Journal of American Statistical Association. J Am Stat Assoc 82:1147\u20131149","journal-title":"J Am Stat Assoc"},{"key":"2328_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000496183","volume":"12","author":"D Durrer Schutz","year":"2019","unstructured":"Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, Pryke R, Toplak H, Widmer D, Yumuk V, Schutz Y (2019) European practical and patient-centred guidelines for adult obesity management in primary care. Obesity Facts 12:40\u201366","journal-title":"Obesity Facts"},{"key":"2328_CR23","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"Diabetes Prevention Program Research Group","year":"2009","unstructured":"Diabetes Prevention Program Research Group (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677\u20131686","journal-title":"Lancet"},{"key":"2328_CR24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","volume":"34","author":"RR Wing","year":"2011","unstructured":"Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L, Look AHEAD Research Group (2011) Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34:1481\u20131486","journal-title":"Diabetes Care"},{"key":"2328_CR25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diacare.22.6.960","volume":"22","author":"RR Holman","year":"1999","unstructured":"Holman RR, Cull CA, Turner RC (1999) A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 22:960\u2013964","journal-title":"Diabetes Care"},{"key":"2328_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321:405\u2013412","journal-title":"Br Med J"},{"key":"2328_CR27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11010-017-3054-5","volume":"435","author":"M Tajfard","year":"2017","unstructured":"Tajfard M, Latiff LA, Rahimi HR, Moohebati M, Hasanzadeh M, Emrani AS, Esmaeily H, Taghipour A, Mirhafez SR, Ferns GA, Mardan-Nik M, Mohammadzadeh E, Avan A, Ghayour-Mobarhan M (2017) Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography. Mol Cell Biochem 435:37\u201345","journal-title":"Mol Cell Biochem"},{"key":"2328_CR28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403","journal-title":"N Engl J Med"},{"key":"2328_CR29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1080\/14656566.2017.1363888","volume":"18","author":"A Ohta","year":"2017","unstructured":"Ohta A, Kato H, Ishii S, Sasaki Y, Nakamura Y, Nakagawa T, Nagai Y, Tanaka Y (2017) Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes. Expert Opin Pharmacother 18:1433\u20131438","journal-title":"Expert Opin Pharmacother"},{"key":"2328_CR30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1507\/endocrj.EJ17-0113","volume":"64","author":"R Kashiwagi","year":"2017","unstructured":"Kashiwagi R, Iwahashi H, Yamada Y, Sakaue T, Okita T, Kawachi Y, Iwamoto R, Saisho K, Tamba S, Yamamoto K, Watanabe T, Fujimoto T, Matsuzawa Y (2017) Effective waist circumference reduction rate necessary to avoid the development of type 2 diabetes in Japanese men with abdominal obesity. Endocr J 64:881\u2013894","journal-title":"Endocr J"},{"key":"2328_CR31","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.clnu.2015.01.004","volume":"34","author":"IJ Onakpoya","year":"2015","unstructured":"Onakpoya IJ, Heneghan CJ (2015) Effect of the novel functionalfibre, polyglycoplex (PGX), on bodyweight and metabolic parameters: A systematic review of randomizedclinical trials. Clin Nutr 34:1109\u20131114","journal-title":"Clin Nutr"},{"key":"2328_CR32","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3945\/jn.112.163204","volume":"142","author":"RA Reimer","year":"2012","unstructured":"Reimer RA, Grover GJ, Koetzner L, Gahler R, Juneja P, Lyon MR, Wood S (2012) Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats. J Nutr 142:1812\u20131820","journal-title":"J Nutr"},{"key":"2328_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nut.2018.05.036","volume":"57","author":"M Jane","year":"2019","unstructured":"Jane M, McKay J, Pal S (2019) Effects of daily consumption of psyllium, oat bran and polyGlycopleXon obesity-related disease risk factors: A critical review. Nutrition 57:84\u201391","journal-title":"Nutrition"},{"key":"2328_CR34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/nu6031115","volume":"6","author":"RA Reimer","year":"2014","unstructured":"Reimer RA, Maathuis AJH, Venema K, Lyon MR, Gahler RJ, Wood S (2014) Effect of the novel polysaccharide polyglycoplex\u00ae on short-chain fatty acid production in a computer-controlled in vitro model of the human large intestine. Nutrients 6:1115\u20131127","journal-title":"Nutrients"},{"key":"2328_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1753-4887.2011.00388.x","volume":"69","author":"E Hosseini","year":"2011","unstructured":"Hosseini E, Grootaert C, Verstraete W, Van de Wiele T (2011) Propionate as a health-promoting microbial metabolite in the human gut. Nutr Rev 69:245\u2013258","journal-title":"Nutr Rev"},{"key":"2328_CR36","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/mnfr.201600305","volume":"60","author":"K Weitkunat","year":"2016","unstructured":"Weitkunat K, Schumann S, Nickel D, Kappo KA, Petzke KJ, Kipp AP, Blaut M, Klaus S (2016) Importance of propionate for the repression of hepaticlipogenesis and improvement of insulin sensitivityin high-fat diet-induced obesity. Mol Nutr Food Res 60:2611\u20132621","journal-title":"Mol Nutr Food Res"},{"key":"2328_CR37","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1021\/acs.jafc.7b04666","volume":"65","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Liu J, Hao W, Zhu H, Liang N, He Z, Ma KY, Chen Z-Y (2017) Structure-specific effects of short-chain fatty acids on plasma cholesterol concentration in male syrian hamsters. J Agric Food Chem 65:10984\u201310992","journal-title":"J Agric Food Chem"},{"key":"2328_CR38","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aao5774","volume":"359","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, Yu L, Xu C, Ren Z, Xu Y, Xu S, Shen H, Zhu X, Shi Y, Shen Q, Dong W, Liu R, Ling Y, Zeng Y, Wang X, Zhang Q, Wang J, Wang L, Wu Y, Zeng B, Wei H, Zhang M, Peng Y, Zhang C (2018) Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359:1151\u20131156","journal-title":"Science"},{"key":"2328_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2019.1613124","volume":"11","author":"C Lordan","year":"2020","unstructured":"Lordan C, Thapa D, Ross RP, Cotter PD (2020) Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components. Gut Microbes 11:1\u201320","journal-title":"Gut Microbes"},{"issue":"8","key":"2328_CR40","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/nu10080988","volume":"10","author":"K Hiippala","year":"2018","unstructured":"Hiippala K, Jouhten H, Ronkainen A, Hartikainen A, Kainulainen V, Jalanka J, Satokari R (2018) The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients 10(8):988","journal-title":"Nutrients"},{"key":"2328_CR41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ismej.2014.177","volume":"9","author":"J Xu","year":"2015","unstructured":"Xu J, Lian F, Zhao L, Zhao Y, Chen X, Zhang X, Guo Y, Zhang C, Zhou Q, Xue Z, Pang X, Zhao L, Tong X (2015) Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J 9:552\u2013562","journal-title":"ISME J"},{"key":"2328_CR42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2017.05.055","volume":"153","author":"AC Nicolucci","year":"2017","unstructured":"Nicolucci AC, Hume MP, Martinez I, Mayengbam S, Walter J, Reimer RA (2017) Prebiotic reduces body fat and alters intestinal microbiota in children with overweight or obesity. Gastroenterology 153:711\u2013722","journal-title":"Gastroenterology"},{"issue":"12","key":"2328_CR43","first-page":"1","volume":"9","author":"JL Carlson","year":"2017","unstructured":"Carlson JL, Erickson JM, Hess JM, Gould TJ, Slavin JL (2017) Prebiotic dietary fiber and gut health: comparing the in vitro fermentations of beta-glucan. Inulin and Xylooligosaccharide Nutrients 9(12):1\u201317","journal-title":"Inulin and Xylooligosaccharide Nutrients"},{"key":"2328_CR44","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/gutjnl-2012-303304","volume":"62","author":"EM Dewulf","year":"2013","unstructured":"Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, Bindels LB, de Vos WM, Gibson GR, Thissen JP, Delzenne NM (2013) Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62:1112\u20131121","journal-title":"Gut"},{"key":"2328_CR45","doi-asserted-by":"crossref","unstructured":"Jiandani D, Wharton S, Rotondi MA, Ardern CI, Kuk JL (2016) Predictors of early attrition and successful weight loss in patients attending an obesity management program. BMC Obes Mar 9;3:14","DOI":"10.1186\/s40608-016-0098-0"},{"key":"2328_CR46","unstructured":"EFSA Panel on Dietetics Products NaA, Turck D, Bresson JL et al (2017) Safety of alginate-konjac-xanthan polysaccharide complex (PGX) as a novel food pursuant to Regulation (EC) No 258\/97. EFSA Journal Adopted 4 April 2017"},{"key":"2328_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2891-8-1","volume":"8","author":"RA Matulka","year":"2009","unstructured":"Matulka RA, Lyon MR, Wood S, Marone PA, Merkel DJ, Burdock GA (2009) The safety of PolyGlycopleX\u00ae (PGX\u00ae) as shown in a 90-day rodent feeding study. Nutr J 8:1\u201311","journal-title":"Nutr J"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-020-02328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-020-02328-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-020-02328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T23:57:44Z","timestamp":1625702264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-020-02328-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1007\/s00394-020-02328-8","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"RAR and S Wood receive consulting fees from InovoBiologic Inc. RAR received financial support for the preparation of this manuscript. S Wharton received funds to pay clinical staff for the conduct of the study. S Wood has an InovoBiologic Inc. patent pending. MRL receives consulting fees from the Factors Group of Companies and holds various patents on PGX<sup>\u00ae<\/sup>. RJG is the owner of the Factors Group of Companies and holds various patents on PGX. TG, PM and HRR declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}